METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Dudov Temirlan Ruslanovich, Koroj Pavel Vladimirovich, Kravchenko Yuliya Aleksandrovna, Yagoda Aleksandr Valentinovich, Slyadnev Sergej Aleksandrovich, Lipov Andrej Vasilevich
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS SURGERY TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Dudov Temirlan Ruslanovich Koroj Pavel Vladimirovich Kravchenko Yuliya Aleksandrovna Yagoda Aleksandr Valentinovich Slyadnev Sergej Aleksandrovich Lipov Andrej Vasilevich
description	FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by calculating the risk of the presence or absence of severe hepatic fibrosis in the patient.EFFECT: method allows for an increase in the sensitivity, specificity and accuracy of the study.1 cl, 5 ex Изобретение относится к области медицины и используется в гастроэнтерологии. Определяют плазменное содержание молекулы адгезии сосудистого эндотелия-1 (Vascular Cell Adhesion Molecule, VСАМ-1), активность AcAT, плазменное содержание молекулы межклеточной адгезии-1 (Intercellular Adhesion Molecule, VCAM-1) и Р-селектина, с дальнейшим расчетом риска наличия или отсутствия тяжелого фиброза печени у пациента. Способ позволяет повысить чувствительность, специфичность и точность исследования. 5 пр.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2765847C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2765847C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2765847C13</originalsourceid><addsrcrecordid>eNqNi0sKwjAQQLtxIeod5gJd-K3bmEzMQExKZlRc1SJxJVqo90cLHsDVg8d74-J6QHHRgI0J6oSGtFDYA-MJE4LDWglpsLRLkYmBAgwGgzCcSRyEGErldXTRD50SuYCn7wyGGBXjtBjd20efZz9OCrAo2pW5ezW579pbfuZ3k46LarPerio9X_6RfAAjRTNI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</title><source>esp@cenet</source><creator>Dudov Temirlan Ruslanovich ; Koroj Pavel Vladimirovich ; Kravchenko Yuliya Aleksandrovna ; Yagoda Aleksandr Valentinovich ; Slyadnev Sergej Aleksandrovich ; Lipov Andrej Vasilevich</creator><creatorcontrib>Dudov Temirlan Ruslanovich ; Koroj Pavel Vladimirovich ; Kravchenko Yuliya Aleksandrovna ; Yagoda Aleksandr Valentinovich ; Slyadnev Sergej Aleksandrovich ; Lipov Andrej Vasilevich</creatorcontrib><description>FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by calculating the risk of the presence or absence of severe hepatic fibrosis in the patient.EFFECT: method allows for an increase in the sensitivity, specificity and accuracy of the study.1 cl, 5 ex Изобретение относится к области медицины и используется в гастроэнтерологии. Определяют плазменное содержание молекулы адгезии сосудистого эндотелия-1 (Vascular Cell Adhesion Molecule, VСАМ-1), активность AcAT, плазменное содержание молекулы межклеточной адгезии-1 (Intercellular Adhesion Molecule, VCAM-1) и Р-селектина, с дальнейшим расчетом риска наличия или отсутствия тяжелого фиброза печени у пациента. Способ позволяет повысить чувствительность, специфичность и точность исследования. 5 пр.</description><language>eng ; rus</language><subject>DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; SURGERY ; TESTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220203&DB=EPODOC&CC=RU&NR=2765847C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220203&DB=EPODOC&CC=RU&NR=2765847C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dudov Temirlan Ruslanovich</creatorcontrib><creatorcontrib>Koroj Pavel Vladimirovich</creatorcontrib><creatorcontrib>Kravchenko Yuliya Aleksandrovna</creatorcontrib><creatorcontrib>Yagoda Aleksandr Valentinovich</creatorcontrib><creatorcontrib>Slyadnev Sergej Aleksandrovich</creatorcontrib><creatorcontrib>Lipov Andrej Vasilevich</creatorcontrib><title>METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</title><description>FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by calculating the risk of the presence or absence of severe hepatic fibrosis in the patient.EFFECT: method allows for an increase in the sensitivity, specificity and accuracy of the study.1 cl, 5 ex Изобретение относится к области медицины и используется в гастроэнтерологии. Определяют плазменное содержание молекулы адгезии сосудистого эндотелия-1 (Vascular Cell Adhesion Molecule, VСАМ-1), активность AcAT, плазменное содержание молекулы межклеточной адгезии-1 (Intercellular Adhesion Molecule, VCAM-1) и Р-селектина, с дальнейшим расчетом риска наличия или отсутствия тяжелого фиброза печени у пациента. Способ позволяет повысить чувствительность, специфичность и точность исследования. 5 пр.</description><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>SURGERY</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0sKwjAQQLtxIeod5gJd-K3bmEzMQExKZlRc1SJxJVqo90cLHsDVg8d74-J6QHHRgI0J6oSGtFDYA-MJE4LDWglpsLRLkYmBAgwGgzCcSRyEGErldXTRD50SuYCn7wyGGBXjtBjd20efZz9OCrAo2pW5ezW579pbfuZ3k46LarPerio9X_6RfAAjRTNI</recordid><startdate>20220203</startdate><enddate>20220203</enddate><creator>Dudov Temirlan Ruslanovich</creator><creator>Koroj Pavel Vladimirovich</creator><creator>Kravchenko Yuliya Aleksandrovna</creator><creator>Yagoda Aleksandr Valentinovich</creator><creator>Slyadnev Sergej Aleksandrovich</creator><creator>Lipov Andrej Vasilevich</creator><scope>EVB</scope></search><sort><creationdate>20220203</creationdate><title>METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</title><author>Dudov Temirlan Ruslanovich ; Koroj Pavel Vladimirovich ; Kravchenko Yuliya Aleksandrovna ; Yagoda Aleksandr Valentinovich ; Slyadnev Sergej Aleksandrovich ; Lipov Andrej Vasilevich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2765847C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2022</creationdate><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>SURGERY</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>Dudov Temirlan Ruslanovich</creatorcontrib><creatorcontrib>Koroj Pavel Vladimirovich</creatorcontrib><creatorcontrib>Kravchenko Yuliya Aleksandrovna</creatorcontrib><creatorcontrib>Yagoda Aleksandr Valentinovich</creatorcontrib><creatorcontrib>Slyadnev Sergej Aleksandrovich</creatorcontrib><creatorcontrib>Lipov Andrej Vasilevich</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dudov Temirlan Ruslanovich</au><au>Koroj Pavel Vladimirovich</au><au>Kravchenko Yuliya Aleksandrovna</au><au>Yagoda Aleksandr Valentinovich</au><au>Slyadnev Sergej Aleksandrovich</au><au>Lipov Andrej Vasilevich</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</title><date>2022-02-03</date><risdate>2022</risdate><abstract>FIELD: medicine.SUBSTANCE: invention relates to the field of medicine and is used in gastroenterology. The plasma content of the vascular cell adhesion molecule-1 (VCAM-1), AsAT activity, the plasma content of the intercellular adhesion molecule-1 (ICAM-1) and P-selectin are determined, followed by calculating the risk of the presence or absence of severe hepatic fibrosis in the patient.EFFECT: method allows for an increase in the sensitivity, specificity and accuracy of the study.1 cl, 5 ex Изобретение относится к области медицины и используется в гастроэнтерологии. Определяют плазменное содержание молекулы адгезии сосудистого эндотелия-1 (Vascular Cell Adhesion Molecule, VСАМ-1), активность AcAT, плазменное содержание молекулы межклеточной адгезии-1 (Intercellular Adhesion Molecule, VCAM-1) и Р-селектина, с дальнейшим расчетом риска наличия или отсутствия тяжелого фиброза печени у пациента. Способ позволяет повысить чувствительность, специфичность и точность исследования. 5 пр.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; rus
recordid	cdi_epo_espacenet_RU2765847C1
source	esp@cenet
subjects	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS SURGERY TESTING
title	METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T04%3A42%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dudov%20Temirlan%20Ruslanovich&rft.date=2022-02-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2765847C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true